Literature DB >> 16051338

Occult lymph node metastases in early stage vulvar carcinoma patients.

Synne Knopp1, Ruth Holm, Claes Tropé, Jahn M Nesland.   

Abstract

OBJECTIVE: In early stage vulvar carcinoma patients, there is at trend towards individualized treatment in order to reduce morbidity and sequela following inguinal lymph node dissection. However, recurrences in the groin are almost always fatal. In the present study, we address the occult lymph node metastases in vulvar squamous cell carcinoma patients by using serial sectioning and immunostaining of lymph nodes in a larger series of vulvar carcinoma patients and relate the findings to clinical follow-up data.
METHODS: From 75 vulvar squamous cell carcinoma patients staged surgical FIGO I-III, 421 lymph nodes found negative at the hematoxylin &amp; eosin (H&amp;E) routine investigation were scrutinized. From formalin-fixed and paraffin-embedded tissues, sections were cut with 150 mum interval and stained with H&amp;E and cytokeratin AE1/AE3. Two classes were used to describe the amount of tumor cells: <100 cells and >100 cells.
RESULTS: Positive cytokeratin AE1/AE3 staining was found in 25/421 (6%) of the lymph nodes. Occult lymph node metastases were found in 17/75 (23%) of the patients. Correlation was found between lymph node metastasis and site of recurrence (P = 0.01). Twenty-eight percent of the patients had relapse.
CONCLUSIONS: The present study underlines the importance of serial sectioning and immunostaining of lymph nodes in the search for micrometastases in vulvar carcinoma patients. However, the results of the present study do not suggest a more thorough examination of non-sentinel lymph nodes in vulvar carcinoma patients where the sentinel lymph nodes are thoroughly examined.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16051338     DOI: 10.1016/j.ygyno.2005.06.023

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  4 in total

1.  Sentinel lymph node detection and accuracy in vulvar cancer: Experience of a tertiary center in Turkey.

Authors:  Nurettin Boran; Derya Akdağ Cırık; Zuhal Işıkdoğan; Metin Kır; Taner Turan; Gökhan Tulunay; Mehmet Faruk Köse
Journal:  J Turk Ger Gynecol Assoc       Date:  2013-09-01

2.  Estimation of groin recurrence risk in patients with squamous cell vulvar carcinoma by the assessment of marker gene expression in the lymph nodes.

Authors:  Magdalena Kowalewska; Jakub Radziszewski; Krzysztof Goryca; Mateusz Bujko; Malgorzata Oczko-Wojciechowska; Michal Jarzab; Janusz Aleksander Siedlecki; Mariusz Bidzinski
Journal:  BMC Cancer       Date:  2012-06-06       Impact factor: 4.430

Review 3.  Ultrastaging of lymph node in uterine cancers.

Authors:  Corinne Bézu; Charles Coutant; Marcos Ballester; Jean-Guillaume Feron; Roman Rouzier; Serge Uzan; Emile Daraï
Journal:  J Exp Clin Cancer Res       Date:  2010-01-21

Review 4.  Lymphatic mapping and sentinel node biopsy in gynecological cancers: a critical review of the literature.

Authors:  Ali Ayhan; Husnu Celik; Polat Dursun
Journal:  World J Surg Oncol       Date:  2008-05-20       Impact factor: 2.754

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.